France To Fast-Track COVID-19 Clinical Trial Applications
Regulator Also Advises On Prioritizing Other Studies
Executive Summary
The continuing spread of the pandemic has led France to introduce accelerated procedures for approving clinical trials of therapies for patients infected by the coronavirus.
You may also be interested in...
EU Urges Sponsors To Assess COVID-19 Impact Before Starting New Trials
New EU guidance on managing clinical trials in the context of COVID-19 requires sponsors to critically assess the feasibility of starting a new clinical trial or including new participants in an ongoing trial. A separate survey indicates that patient willingness to participate in new trials has dramatically declined due to the pandemic.
NGOs Praise C-TAP COVID-19 Deals But Say Much More Needs To Be Done
With efforts continuing to maximize access to medical countermeasures against the pandemic threat, a webinar organized by NGOs looked at progress with and the shortcomings of the WHO’s C-TAP initiative, recent moves by the WHO on access provisions in funding agreements, and plans for a global C-TAP database.
NGOs Praise C-TAP COVID-19 Deals But Say Much More Needs To Be Done
With efforts continuing to maximize access to medical countermeasures against the pandemic threat, a webinar organized by NGOs looked at progress with and the shortcomings of the WHO’s C-TAP initiative, recent moves by the WHO on access provisions in funding agreements, and plans for a global C-TAP database.